Aurobindo Pharma Board of Directors
Get the latest insights into the leadership at Aurobindo Pharma. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mangalam Ramasubramanian Kumar | Chairman |
| K Nityananda Reddy | Vice Chairman & Managing Director |
| M Madan Mohan Reddy | Whole Time Director |
| Santanu Mukherjee | Non Executive Independent Director |
| Girish Paman Vanvari | Non Executive Independent Director |
| Deepali Pant Joshi | Non Executive Independent Director |
| P Sarath Chandra Reddy | Non Independent & Non Executive Director |
| Satakarni Makkapati | Non Independent & Non Executive Director |
| PV Ramprasad Reddy | Promoter & Non-Executive Director |
| B Adi Reddy | Company Secretary & Compliance Officer |
Aurobindo Pharma FAQs
The board at Aurobindo Pharma consists of experienced professionals, including Mangalam Ramasubramanian Kumar, K Nityananda Reddy, and others, overseeing the company’s strategic and corporate governance.
Directors at Aurobindo Pharma are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mangalam Ramasubramanian Kumar is the current chairman at Aurobindo Pharma.
Executive directors at Aurobindo Pharma are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Aurobindo Pharma adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Aurobindo Pharma, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
Aurobindo Pharma Associated Pages
